Menu
Currency
GWAS Study

Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.

Liu N, Irvin MR, Zhi D et al.

28686080 PubMed ID
GWAS Study Type
1707 Participants
60 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LN
Liu N
IM
Irvin MR
ZD
Zhi D
PA
Patki A
BT
Beasley TM
ND
Nickerson DA
HC
Hill CE
CJ
Chen J
KS
Kimmel SE
LN
Limdi NA
Chapter II

Abstract

Summary of the research findings

Aim: We conducted a genome-wide association study using the Illumina Exome Array to identify coding SNPs that may explain additional warfarin dose variability.

701 European ancestry individuals, 539 African American individuals

Chapter III

Study Statistics

Key metrics and study information

1707
Total Participants
GWAS
Study Type
Yes
Replicated
137 European Ancestry individuals, 330 African American individuals
Replication Participants
African American or Afro-Caribbean, European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.